The same goes for individuals suffering from certain genetic issues
Other safety topics clinicians monitor include hypoglycaemia risk (low blood sugar, more common with insulin/sulfonylureas), pancreatitis/gallbladder disease, and eyerelated safety signals
Important safety information : Semaglutide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment) Insulin-Like Growth Factor I (IGF-I) ACTH, Plasma Estrone, LC/MS/MS Estradiol, Ultrasensitive, LC/MS/MS Sex Hormone binding Globulin, Serum Pregnenolone, LC/MS Homocysteine, Cardiovascular Tri-iodothyronine Free (FT3) Thyroxine Free, Direct Dialysis (FT4) Total Testosterone, Free (Dialysis) Testosterone (calculated) Copper, Serum or Plasma Dehydroepiandrosterone (DHEA-s) Sulfate Cortisol, AM Fibrinogen Activity Hemoglobin (Hgb) A1c Thyroid Peroxidase (TPO) Antibodies Growth Hormone, Serum Prostate-Specific Antigen (PSA), Total Insulin Follicle-stimulating Hormone (FSH) and Luteinizing Hormone (LH) Progesterone, serum Prolactin, serum Thyroid-Stimulating Hormone (TSH) Dihydrotestosterone, LC/MS/MS Reverse Tri-iodothyronine (RT3) Cardio IQ Cholesterol, Total
Our products are routinely and rigorously tested for purity, with COAs verifiable through third-party laboratory testing services
